A new technique enables the use of fatty acids—for example, those found in cooking oil from fast-food restaurants—to dissolve ...

Sagimet Biosciences Inc.’s SGMT share price has surged by 6.88%, which has investors questioning if this is right time to sell.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Sagimet Biosciences, Inc. Class A ( ($SGMT) ) has released its Q1 earnings. Here is a breakdown of the information Sagimet Biosciences, Inc. Class ...

These observations led to the discovery of acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS), the two key enzymes of fatty acid synthesis. His laboratory was the first to identify these ...

Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

and fatty acids is coupled to the generation of an electrochemical gradient across the inner mitochondrial membrane, which is harnessed by the ATP synthase to drive the formation of ATP.

Expert Rev Cardiovasc Ther. 2008;6(3):391-409. Phosphatidic acid phosphatase/phosphohydrolase (PAP) is an enzyme that catalyzes the conversion of phosphatidic acid to ...